Results 131 to 140 of about 324,899 (254)

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Declining trends in adolescent alcohol consumption and related harms: No room for complacency (an empirical reply to Vieira et al. 2025)

open access: yesAddiction, EarlyView.
Abstract Vieira et al. report that alcohol‐related harms among adolescents have generally declined in high‐income countries where youth drinking has decreased, but several methodological choices complicate this conclusion. By performing reproducibility analyses on Vieira et al.'s raw data, we show that their findings are more nuanced and complex ...
Charlotte R. Pennington   +4 more
wiley   +1 more source

Coronavirus Disease 2019 (COVID-19) and Cardiac Injury [PDF]

open access: yesJAMA Cardiology, 2020
Heffernan, Kevin S.   +2 more
openaire   +2 more sources

Discrimination experiences are associated with same‐day and next‐day smoking among adults with low socio‐economic status trying to quit: A secondary analysis of data from a randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and aims Research indicates that experiencing discrimination may be associated with a return to smoking following a quit attempt. The current study aimed to characterize day‐to‐day relations between discrimination and smoking in the context of a smoking cessation trial for adults with socio‐economic disadvantage.
Laili K. Boozary   +10 more
wiley   +1 more source

The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial

open access: yesAddiction, EarlyView.
Abstract Background and aims Mindfulness‐based relapse prevention (MBRP) has been shown to be beneficial to individuals with substance use disorder (SUD) in the West. The current pilot study aimed at testing the feasibility of MBRP in a Chinese population.
Ka Tsun Ting   +11 more
wiley   +1 more source

The Ability of Serum Amyloid A to Discriminate Coronavirus Disease 2019 (COVID-19) Patients Who Stay Moderately Ill Versus Patients Who Become Severely Ill. [PDF]

open access: yesJ Clin Lab Anal
Pouw NMC   +8 more
europepmc   +1 more source

Diagnostic options for coronavirus disease 2019 (COVID-19) [PDF]

open access: yesInfection Control & Hospital Epidemiology, 2020
Xiao, Yuanyuan   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy